+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Release of norepinephrine and dopamine from brain vesicular preparations effects of calcium antagonists



Release of norepinephrine and dopamine from brain vesicular preparations effects of calcium antagonists



Cellular & Molecular Neurobiology 2(3): 205-214



The Ca antagonists D-600 [methoxy verapamil] (1-10 .mu.M) and diltiazem (10-25 .mu.M) inhibit K+-evoked release of [3H]norepinephrine from guinea pig cerebral cortical vesicular preparations. The inhibition of release is partially reversed by increasing concentrations of calcium to 2 mM. Diltiazem at 100 .mu.M has no effect on K+-evoked release of [3H]norepinephrine at 0.15 mM Ca but does inhibit release at 2.0 mM Ca. The Ca antagonists nifedipine and dantrolene, agents purported to antagonize release of Ca from intracellular storage sites, have no effect on K+-evoked release of [3H]norepinephrine. The calcium antagonists, D-600 (1 .mu.M) and diltiazem (10 .mu.M), inhibit K+-evoked release of [3H]dopamine from guinea pig striatal vesicular preparations. Higher concentrations of drug, namely, 10 .mu.M for D-600 and 100 .mu.M for diltiazem, cause a potentiation rather than an inhibition of K+-evoked release. The potentiation is reduced in magnitude upon raising the extracellular Ca to 2.0 mM. Indeed, 10 .mu.M D-600 then inhibits K+-evoked release of [3H]dopamine. Putative Ca antagonists can have both inhibitory and facilitory effects on Ca-dependent K+-evoked release of catecholamines from central synaptic endings. Furthermore, certain peripheral Ca antagonists, such as nifedipine and dantrolene, may prove ineffective in central systems.

(PDF emailed within 0-6 h: $19.90)

Accession: 006306183

Download citation: RISBibTeXText

PMID: 7159902

DOI: 10.1007/bf00711148


Related references

Release of norepinephrine and dopamine from brain vesicular preparations effects of adenosine analogs. Cellular & Molecular Neurobiology 2(3): 193-204, 1982

Release of norepinephrine from brain vesicular preparations: effects of an adenylate cyclase activator, forskolin, and a phosphodiesterase inhibitor. Cellular and Molecular Neurobiology 2(3): 179-192, 1982

Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neuroscience Letters 133(1): 77-80, 1991

Effects of calcium antagonists on release of tritium labeled norepinephrine in rabbit aorta. Japanese Journal of Pharmacology 33(SUPPL): 172P, 1983

Effects of calcium-antagonists on norepinephrine release from sympathetic nerve endings in rat mesenteric vasculature. Japanese Heart Journal 27(3): 395-402, 1986

Effects of calcium channel antagonists on the depolarization-evoked release of norepinephrine in the rabbit iris-ciliary body. Neuroscience Letters 88(3): 286-290, 1988

Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain. Research Communications in Chemical Pathology and Pharmacology 49(3): 467-470, 1985

Effects of nicotine on distribution and release of 14C-norepinephrine and 14C-dopamine in rat brain striatum and hypothalamus slices. Neuropharmacology 13(10-11): 1025-1032, 1974

Effects of the d- and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain. Biochemical Pharmacology 25(4): 447-451, 1976

Comparison of the effects of voltage-sensitive calcium channel antagonism on the electrically stimulated release of dopamine and norepinephrine in vivo. Brain Research. 604(1-2): 349-353, 1993

Different anesthesia preparations reveal appropriate responses of dopamine mid brain neurons to dopamine agonist and antagonists drugs. Society for Neuroscience Abstracts 12(1): 489, 1986

Effects of calcium antagonists on the norepinephrine release and contractile responses of isolated canine saphenous veins to trans mural nerve stimulation. Japanese Journal of Pharmacology 34(4): 397-410, 1984

Effects of tetrodotoxin, elevated calcium and calcium antagonists on electrically induced 3H-noradrenaline release from brain slices. European Journal of Pharmacology 44(3): 275-278, 1977

The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations. Cellular and Molecular Neurobiology 3(3): 191-201, 1983

Different effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brain. Journal of Neural Transmission 75(3): 195-200, 1989